{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:02:33Z","timestamp":1789509753683,"version":"build-2803163510"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006065","name":"Government of Western Australia Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"publisher","award":["2004608"],"award-info":[{"award-number":["2004608"]}],"id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2035042"],"award-info":[{"award-number":["GNT2035042"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031198","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA165995"],"award-info":[{"award-number":["CA165995"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011025","name":"Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.042","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:01:08Z","timestamp":1788188468000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR\/dCas9 silencers"],"prefix":"10.1016","author":[{"given":"Shahama","family":"Taifour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash W.J.","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Waryah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-1965","authenticated-orcid":false,"given":"Mahnaz","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9713-1861","authenticated-orcid":false,"given":"Dilys","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Lister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Dymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Swaminathan","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marck","family":"Norret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron W.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Winteringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Gaudieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3881-7396","authenticated-orcid":false,"given":"Pilar","family":"Blancafort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.042_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41467-019-09551-w","article-title":"Multiplexed Cas9 targeting reveals genomic location effects and gRNA-based staggered breaks influencing mutation efficiency","volume":"10","author":"Gisler","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.042_bib2","series-title":"Epigenome Editing: Methods and Protocols","first-page":"19","article-title":"Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing","author":"Waryah","year":"2018"},{"key":"10.1016\/j.ymthe.2026.08.042_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902552","article-title":"Innovative Precision Gene-Editing Tools in Personalized Cancer Medicine","volume":"7","author":"Dai","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.042_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.042_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.042_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.08.042_bib8","article-title":"CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research","volume":"10","author":"Martinez-Escobar","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7834175","article-title":"Novel Epigenetic Techniques Provided by the CRISPR\/Cas9 System","volume":"2018","author":"Xie","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.ymthe.2026.08.042_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13072-019-0275-8","article-title":"Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner","volume":"12","author":"O\u2019Geen","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.ymthe.2026.08.042_bib11","doi-asserted-by":"crossref","first-page":"12453","DOI":"10.1093\/nar\/gkaa1000","article-title":"Epigenome engineering: new technologies for precision medicine","volume":"48","author":"Sgro","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41591-022-01717-2","article-title":"Delivering precision oncology to patients with cancer","volume":"28","author":"Mateo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.042_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2018.01.002","article-title":"Hallmarks of cancer: The CRISPR generation","volume":"93","author":"Moses","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymeth.2020.04.006","article-title":"Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects","volume":"187","author":"Rahman","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2026.08.042_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-biochem-060815-014607","article-title":"CRISPR\/Cas9 in Genome Editing and Beyond","volume":"85","author":"Wang","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2026.08.042_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acschembio.7b00657","article-title":"CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine","volume":"13","author":"Kampmann","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib19","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1073\/pnas.91.10.4509","article-title":"Kr\u00fcppel-associated boxes are potent transcriptional repression domains","volume":"91","author":"Margolin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.042_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature08674","article-title":"KAP1 controls endogenous retroviruses in embryonic stem cells","volume":"463","author":"Rowe","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.042_bib21","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1101\/gad.1102803","article-title":"Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation","volume":"17","author":"Ayyanathan","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.08.042_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1101\/gad.973302","article-title":"SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins","volume":"16","author":"Schultz","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.08.042_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1101\/gad.869501","article-title":"Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD","volume":"15","author":"Schultz","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2026.08.042_bib24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","article-title":"Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements","volume":"12","author":"Thakore","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.042_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nmeth.3325","article-title":"Functional annotation of native enhancers with a Cas9-histone demethylase fusion","volume":"12","author":"Kearns","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.042_bib26","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ymthe.2026.08.042_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.08.042_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd.2016.280","article-title":"Delivery technologies for genome editing","volume":"16","author":"Yin","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.08.042_bib30","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib31","first-page":"267","article-title":"Protocol for Delivery of CRISPR\/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA","volume":"2842","author":"Woodward","year":"2024"},{"key":"10.1016\/j.ymthe.2026.08.042_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biomaterials.2018.04.031","article-title":"Non-viral delivery systems for CRISPR\/Cas9-based genome editing: Challenges and opportunities","volume":"171","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2026.08.042_bib33","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1039\/D1BM01452H","article-title":"Pre-clinical non-viral vectors exploited for in vivo CRISPR\/Cas9 gene editing: an overview","volume":"10","author":"Rouatbi","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib34","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymthe.2026.08.042_bib35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jconrel.2021.08.007","article-title":"Versatile modification of the CRISPR\/Cas9 ribonucleoprotein system to facilitate in vivo application","volume":"337","author":"Sun","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.08.042_bib37","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1021\/jacs.1c00258","article-title":"Regulation of Proteins to the Cytosol Using Delivery Systems with Engineered Polymer Architecture","volume":"143","author":"Kretzmann","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2026.08.042_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.673286","article-title":"Nanoparticle Delivery of CRISPR\/Cas9 for Genome Editing","volume":"12","author":"Duan","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymthe.2026.08.042_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.08.042_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137932","article-title":"Stimuli-responsive peptide nanocarriers for tumor-specific CRISPR\/Cas9 delivery and precision genome editing","volume":"697","author":"Wang","year":"2025","journal-title":"J. Colloid Interf. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12951-025-03214-3","article-title":"Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR\/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ymthe.2026.08.042_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.actbio.2024.10.030","article-title":"A biodegradable lipid nanoparticle delivers a Cas9 ribonucleoprotein for efficient and safe in situ genome editing in melanoma","volume":"190","author":"Yang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ymthe.2026.08.042_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123511","article-title":"Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy","volume":"324","author":"Fang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2026.08.042_bib44","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1039\/C7SC00097A","article-title":"Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA","volume":"8","author":"Kretzmann","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00279","article-title":"Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma","volume":"5","author":"Redini","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.12.009","article-title":"The Biology of Ewing sarcoma","volume":"254","author":"Riggi","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.08.042_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Gr\u00fcnewald","year":"2018","journal-title":"Nat. Rev. Primer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib48","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","article-title":"Ewing Sarcoma: Current Management and Future Approaches Through Collaboration","volume":"33","author":"Gaspar","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.042_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing\u2019s Sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.08.042_bib51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nm.1983","article-title":"A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing\u2019s sarcoma","volume":"15","author":"Erkizan","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.08.042_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2017.07.036","article-title":"Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain","volume":"171","author":"Boulay","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib53","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","article-title":"EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma","volume":"26","author":"Riggi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10555-019-09839-9","article-title":"Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies","volume":"38","author":"Knott","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ymthe.2026.08.042_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3058","article-title":"RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis","volume":"6","author":"S\u00e1nchez-Molina","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.08.042_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110971","article-title":"Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1","volume":"39","author":"Deng","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.08.042_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68257-y","article-title":"Transcriptional repression of PTEN in neural cells using CRISPR\/dCas9 epigenetic editing","volume":"10","author":"Moses","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.08.042_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301802","article-title":"Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR\/dCas9 Platform in Triple Negative Breast Cancer","volume":"10","author":"Waryah","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13148-023-01482-0","article-title":"Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma","volume":"15","author":"Sgro","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib63","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/MCB.18.3.1489","article-title":"EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes","volume":"18","author":"Bertolotti","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fonc.2015.00162","article-title":"EWS\/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma","volume":"5","author":"Cidre-Aranaz","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6605104","article-title":"Stable interference of EWS\u2013FLI1 in an Ewing sarcoma cell line impairs IGF-1\/IGF-1R signalling and reveals TOPK as a new target","volume":"101","author":"Herrero-Mart\u00edn","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-021-00640-x","article-title":"Single-cell RNA profiling identifies diverse cellular responses to EWSR1\/FLI1 downregulation in Ewing sarcoma cells","volume":"45","author":"Khoogar","year":"2022","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib67","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1158\/0008-5472.CAN-07-1761","article-title":"EWS-FLI-1 expression triggers a Ewing\u2019s sarcoma initiation program in primary human mesenchymal stem cells","volume":"68","author":"Riggi","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib68","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1158\/1541-7786.MCR-06-0090","article-title":"NR0B1 is required for the oncogenic phenotype mediated by EWS\/FLI in Ewing\u2019s sarcoma","volume":"4","author":"Kinsey","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib69","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/1541-7786.MCR-14-0159","article-title":"Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors","volume":"12","author":"Anderson","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molcel.2011.05.035","article-title":"The Ewing sarcoma protein regulates DNA damage-induced alternative splicing","volume":"43","author":"Paronetto","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib71","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1054\/bjoc.2000.1652","article-title":"Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes","volume":"84","author":"Matsumoto","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib72","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1158\/1541-7786.MCR-23-1090","article-title":"ETS1, a Target Gene of the EWSR1::FLI1 Fusion Oncoprotein, Regulates the Expression of the Focal Adhesion Protein TENSIN3","volume":"22","author":"Ebegboni","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib73","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1158\/0008-5472.CAN-03-2594","article-title":"Selective usage of D-Type cyclins by Ewing\u2019s tumors and rhabdomyosarcomas","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib74","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1073\/pnas.0710748105","article-title":"Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer","volume":"105","author":"Sanchez","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.042_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000869","article-title":"KRAB\u2013Zinc Finger Proteins and KAP1 Can Mediate Long-Range Transcriptional Repression through Heterochromatin Spreading","volume":"6","author":"Groner","year":"2010","journal-title":"PLOS Genet."},{"key":"10.1016\/j.ymthe.2026.08.042_bib76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-020-02201-1","article-title":"Simultaneous epigenetic perturbation and genome imaging reveal distinct roles of H3K9me3 in chromatin architecture and transcription","volume":"21","author":"Feng","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib77","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1039\/C9SC01432B","article-title":"Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers","volume":"10","author":"Kretzmann","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib78","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1021\/acsnano.6b07600","article-title":"Direct Cytosolic Delivery of CRISPR\/Cas9-Ribonucleoprotein for Efficient Gene Editing","volume":"11","author":"Mout","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2026.08.042_bib79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","article-title":"Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection","volume":"208","author":"Liang","year":"2015","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26870","article-title":"Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models","volume":"65","author":"Bandyopadhyay","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00280-016-3042-6","article-title":"Identifying novel therapeutic agents using xenograft models of pediatric cancer","volume":"78","author":"Kurmasheva","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib82","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.celrep.2019.09.071","article-title":"Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design","volume":"29","author":"Rokita","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.08.042_bib83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-cancerbio-030518-055710","article-title":"Biology and Therapy of Dominant Fusion Oncoproteins Involving Transcription Factor and Chromatin Regulators in Sarcomas","volume":"3","author":"Perry","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib84","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1158\/0008-5472.CAN-07-6145","article-title":"EWS-FLI1 suppresses NOTCH-activated p53 in Ewing\u2019s sarcoma","volume":"68","author":"Ban","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1172\/JCI119152","article-title":"EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing\u2019s sarcoma and primitive neuroectodermal tumor cells","volume":"99","author":"Tanaka","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.08.042_bib86","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1093\/nar\/gkt678","article-title":"Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis","volume":"41","author":"Stoll","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib87","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1128\/MCB.24.16.7275-7283.2004","article-title":"EWS\/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3","volume":"24","author":"Prieur","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ccr.2006.04.004","article-title":"Expression profiling of EWS\/FLI identifies NKX2.2 as a critical target gene in Ewing\u2019s sarcoma","volume":"9","author":"Smith","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib89","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1158\/1078-0432.CCR-14-2112","article-title":"SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma","volume":"21","author":"Tang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib90","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1525-0016(03)00101-1","article-title":"Small interfering RNAs expressed from a Pol III promoter suppress the EWS\/Fli-1 transcript in an Ewing sarcoma cell line","volume":"7","author":"Dohjima","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.042_bib91","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib92","article-title":"Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR\/Cas9 in Ewing Sarcoma","volume":"13","author":"Cervera","year":"2021","journal-title":"Cancers Basel"},{"key":"10.1016\/j.ymthe.2026.08.042_bib93","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41467-020-18875-x","article-title":"In vivo CRISPR\/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells","volume":"11","author":"Martinez-Lage","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.042_bib94","doi-asserted-by":"crossref","first-page":"26027","DOI":"10.18632\/oncotarget.15215","article-title":"The CRISPR\/Cas9 system efficiently reverts the tumorigenic ability of BCR\/ABL in vitro and in a xenograft model of chronic myeloid leukemia","volume":"8","author":"Garc\u00eda-Tu\u00f1\u00f3n","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2026.08.042_bib95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3843","article-title":"Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene","volume":"35","author":"Chen","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib96","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/mt.2016.93","article-title":"Preclinical Justification of pbi-shRNA EWS\/FLI1 Lipoplex (LPX) Treatment for Ewing\u2019s Sarcoma","volume":"24","author":"Rao","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.042_bib97","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nmeth.2600","article-title":"RNA-guided gene activation by CRISPR-Cas9-based transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.042_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051623","article-title":"Routine EWS Fusion Analysis in the Oncology Clinic to Identify Cancer-Specific Peptide Sequence Patterns That Span Breakpoints in Ewing Sarcoma and DSRCT","volume":"15","author":"Anderson","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2026.08.042_bib99","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.042_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA Methylation in the Mammalian Genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib102","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nbt.3658","article-title":"Targeted DNA demethylation in vivo using dCas9\u2013peptide repeat and scFv\u2013TET1 catalytic domain fusions","volume":"34","author":"Morita","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib103","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib104","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1074\/jbc.M001499200","article-title":"Biochemical analysis of the Kruppel-associated box (KRAB) transcriptional repression domain","volume":"275","author":"Peng","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.08.042_bib105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/gb-2003-4-10-231","article-title":"KRAB-containing zinc-finger repressor proteins","volume":"4","author":"Urrutia","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib106","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1093\/nar\/24.24.4859","article-title":"Transcriptional Repression by RING Finger Protein TIF1\u03b2 That Interacts with the KRAB Repressor Domain of KOX1","volume":"24","author":"Moosmann","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib107","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1073\/pnas.91.10.4514","article-title":"The Kr\u00fcppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression","volume":"91","author":"Witzgall","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.042_bib108","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1021\/acs.accounts.8b00292","article-title":"Cellular Uptake of Nanoparticles versus Small Molecules: A Matter of Size","volume":"51","author":"Mosquera","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib109","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.apsb.2021.02.019","article-title":"Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers","volume":"11","author":"Mazumdar","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymthe.2026.08.042_bib110","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/bioinformatics\/btl498","article-title":"Meisetz and the birth of the KRAB motif","volume":"22","author":"Birtle","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib111","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1093\/nar\/gks360","article-title":"Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer","volume":"40","author":"Stolzenburg","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib112","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.celrep.2015.01.042","article-title":"Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1","volume":"10","author":"Tomazou","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.08.042_bib113","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/13854","article-title":"Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein","volume":"23","author":"Hahm","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.08.042_bib114","article-title":"Targeting and editing DNA methylation and hydroxymethylation for gene therapy","volume":"38","author":"Waryah","year":"2026","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.08.042_bib115","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1038\/onc.2012.525","article-title":"Mechanism and relevance of EWS\/FLI-mediated transcriptional repression in Ewing sarcoma","volume":"32","author":"Sankar","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2026.08.042_bib116","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature25748","article-title":"EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma","volume":"555","author":"Gorthi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.042_bib117","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ijc.25564","article-title":"Synthetic siRNA targeting the breakpoint of EWS\/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model","volume":"128","author":"Takigami","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib118","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/path.4867","article-title":"PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma","volume":"241","author":"Pandey","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib119","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41467-020-14362-5","article-title":"Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.042_bib120","doi-asserted-by":"crossref","first-page":"26267","DOI":"10.1074\/jbc.R111.252569","article-title":"KAP1 Protein: An Enigmatic Master Regulator of the Genome","volume":"286","author":"Iyengar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.08.042_bib121","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/onc.2014.470","article-title":"Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer","volume":"34","author":"Stolzenburg","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2026.08.042_bib122","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4161\/epi.19507","article-title":"Epigenetic reprogramming of cancer cells via targeted DNA methylation","volume":"7","author":"Rivenbark","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib123","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.molcel.2017.07.012","article-title":"Methylation of DNA Ligase 1 by G9a\/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation","volume":"67","author":"Ferry","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.08.042_bib124","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/thno.47007","article-title":"Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114087","article-title":"CRISPR\/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells","volume":"181","author":"Bloomer","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.08.042_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210081","article-title":"Carrier strategies boost the application of CRISPR\/Cas system in gene therapy","volume":"2","author":"Xu","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.ymthe.2026.08.042_bib127","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.042_bib128","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41467-024-55137-6","article-title":"Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering","volume":"16","author":"Padilla","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.042_bib129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","volume":"9","author":"Ho\u0142ubowicz","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.08.042_bib130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/crispr.2022.0009","article-title":"Enhanced Myogenesis by Silencing Myostatin with Nonviral Delivery of a dCas9 Ribonucleoprotein Complex","volume":"5","author":"Chen","year":"2022","journal-title":"Crispr J."},{"key":"10.1016\/j.ymthe.2026.08.042_bib131","article-title":"Cellular reprogramming with multigene activation by the delivery of CRISPR\/dCas9 ribonucleoproteins via magnetic peptide-imprinted chitosan nanoparticles","volume":"9","author":"Lee","year":"2021","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ymthe.2026.08.042_bib132","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/pharmaceutics15041311","article-title":"Activation of Insulin Gene Expression via Transfection of a CRISPR\/dCas9a System Using Magnetic Peptide-Imprinted Nanoparticles","volume":"15","author":"Lee","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162584","article-title":"Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove \u03b1-Synuclein from an In Vitro Model","volume":"11","author":"Lee","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.08.042_bib134","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acssynbio.8b00192","article-title":"Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation","volume":"7","author":"Lain\u0161\u010dek","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.ymthe.2026.08.042_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw8922","article-title":"A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing","volume":"5","author":"Liu","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.08.042_bib137","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pnsc.2019.10.003","article-title":"Cationic polymeric nanoformulation: Recent advances in material design for CRISPR\/Cas9 gene therapy","volume":"29","author":"Chen","year":"2019","journal-title":"Prog. Nat. Sci. Mater. Int."},{"key":"10.1016\/j.ymthe.2026.08.042_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1598","article-title":"Polymer-mediated gene therapy: Recent advances and merging of delivery techniques","volume":"12","author":"Salameh","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib139","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2147\/IJN.S222419","article-title":"Biodegradable Polymers for Gene-Delivery Applications","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2026.08.042_bib140","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1021\/nn300500u","article-title":"Single-Step Assembly of Cationic Lipid\u2013Polymer Hybrid Nanoparticles for Systemic Delivery of siRNA","volume":"6","author":"Yang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2026.08.042_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142289","article-title":"In vitro activation of anti-cancer gene expression by delivery of CRISPR\/dCas9 ribonucleoproteins to suppress glioblastoma","volume":"308","author":"Lee","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib142","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1021\/acsnano.7b02884","article-title":"General Strategy for Direct Cytosolic Protein Delivery via Protein-Nanoparticle Co-engineering","volume":"11","author":"Mout","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2026.08.042_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48634-y","article-title":"Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations","volume":"9","author":"Nanni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.08.042_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines","volume":"24","author":"Namiot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib145","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymthe.2026.08.042_bib146","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1039\/D2RA07863E","article-title":"Cancer nanomedicine: a review of nano-therapeutics and challenges ahead","volume":"13","author":"Nirmala","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ymthe.2026.08.042_bib147","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of Clinical Translation of Cancer Nanomedicines\u2014Lessons Learned from Successes and Failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300102","article-title":"Current Status and Trends in Nucleic Acids for Cancer Therapy: A Focus on Polysaccharide-Based Nanomedicines","volume":"23","author":"Molinar","year":"2023","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib149","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.042_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202411032","article-title":"Targeted CRISPR\/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer","volume":"12","author":"Masarwy","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.08.042_bib151","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U","article-title":"MIC2 is a specific marker for Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration","volume":"67","author":"Ambros","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib152","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/bjc.2012.57","article-title":"The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting","volume":"106","author":"Kailayangiri","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib153","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1073\/pnas.1521251113","article-title":"Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target","volume":"113","author":"Town","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.042_bib154","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2407-10-116","article-title":"CD133 expression in chemo-resistant Ewing sarcoma cells","volume":"10","author":"Jiang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ymthe.2026.08.042_bib155","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/nar\/gkac123","article-title":"Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing","volume":"50","author":"O\u2019Geen","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib156","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1093\/nar\/gky171","article-title":"Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells","volume":"46","author":"Mlambo","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib157","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","article-title":"Durable and efficient gene silencing in vivo by hit-and-run epigenome editing","volume":"627","author":"Cappelluti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.08.042_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib159","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib161","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.042_bib162","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acschembio.9b00651","article-title":"Engineered Reader Proteins for Enhanced Detection of Methylated Lysine on Histones","volume":"15","author":"Albanese","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib163","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1083\/jcb.201709115","article-title":"A toolbox of anti\u2013mouse and anti\u2013rabbit IgG secondary nanobodies","volume":"217","author":"Pleiner","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib164","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41587-021-00869-9","article-title":"Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues","volume":"39","author":"Bartosovic","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.042_bib165","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib166","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.08.042_bib167","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","article-title":"Peak calling by Sparse Enrichment Analysis for CUT&RUN chromatin profiling","volume":"12","author":"Meers","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.ymthe.2026.08.042_bib168","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib169","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.08.042_bib170","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab637","article-title":"Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate","volume":"49","author":"Peters","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.08.042_bib171","doi-asserted-by":"crossref","DOI":"10.3791\/51998-v","article-title":"The Soft Agar Colony Formation Assay","author":"Borowicz","year":"2014","journal-title":"J. Vis. Exp. Jove"},{"key":"10.1016\/j.ymthe.2026.08.042_bib172","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/ma052526f","article-title":"Convergent Synthesis of Symmetrical and Unsymmetrical PAMAM Dendrimers","volume":"39","author":"Lee","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.ymthe.2026.08.042_bib173","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.tet.2012.12.073","article-title":"Synthesis of \u03b2-cyclodextrin and poly(amido amine) dendron click cluster and its synergistic binding property","volume":"69","author":"Lin","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ymthe.2026.08.042_bib174","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1021\/acs.nanolett.6b04955","article-title":"Rational Design of a Polymer with Robust Efficacy for Intracellular Protein and Peptide Delivery","volume":"17","author":"Chang","year":"2017","journal-title":"Nano Lett."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:07:06Z","timestamp":1789506426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":173,"alternative-id":["S1525001626007665"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.042","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing sarcoma by CRISPR\/dCas9 silencers","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}